Immunodiagnostic Systems Holdings plc (IDS) launched the IDS Cortisol assay for use with the IDS Automated System in the European market and other countries which accept the CE mark. Measurement of Cortisol concentrations can be used to assist in the diagnosis and treatment of disorders of the adrenal gland, such as hypo- and hyper-cortisolism, most commonly referred to as Addison's disease and Cushing's syndrome. Many common signs of Cushing's such as obesity, high blood pressure and increased blood glucose are frequently observed in today's society. This new assay complements the existing Aldosterone, Direct Renin, ACTH and Salivary Cortisol assays in the IDS Hypertension panel, improving laboratory workflow with the IDS Automated System.